Education
About Us
Working with TipRanks
Follow Us
Design Therapeutics (DSGN)
NASDAQ:DSGN
RESEARCH TOOLSreports
Design Therapeutics (DSGN) Ownership Overview
19.63% Insiders
6.76% Mutual Funds
0.27% Other Institutional Investors
5.93% ETFs
67.41% Public Companies and Individual Investors
The ownership structure of Design Therapeutics (DSGN) stock is a mix of institutional, retail, and individual investors. Approximately 12.97% of the company’s stock is owned by Institutional Investors, 19.63% is owned by Insiders, and 67.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 19, 2024 | Deepa Prasad Director | xxxxxxxxxxxxx | $23864 |
| Aug 12, 2024 | William Arsani Director | xxxxxxxxxxxxx | $3463215 |
| Mar 25, 2024 | John Schmid Director | xxxxxxxxxxxxx | $99659 |
| Mar 25, 2024 | Heather A. Berger Director | xxxxxxxxxxxxx | $4862 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $4788425 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,526,476 | Insider | 11.53% | 24,017,432 | |
| 4,217,627 | Insider | 7.45% | 15,520,867 | |
| 1,743,725 | Institution | 3.08% | 6,416,908 | |
| 1,465,814 | Institution | 2.59% | 5,394,196 | |
| 1,373,630 | Institution | 2.43% | 5,054,958 | |
| 1,200,406 | Institution | 2.12% | 4,417,494 | |
| 839,131 | Institution | 1.48% | 3,088,002 | |
| 356,648 | Institution | 0.63% | 1,312,465 | |
| 281,781 | Institution | 0.50% | 1,036,954 | |
| 275,438 | Institution | 0.49% | 1,013,612 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,200,406 | Institution | 2.12% | 4,417,494 | |
| 839,131 | Institution | 1.48% | 3,088,002 | |
| 356,648 | Institution | 0.63% | 1,312,465 | |
| 281,781 | Institution | 0.50% | 1,036,954 | |
| 275,438 | Institution | 0.49% | 1,013,612 | |
| 224,300 | Institution | 0.40% | 825,424 | |
| 170,463 | Institution | 0.30% | 627,304 | |
| 104,423 | Institution | 0.18% | 384,277 | |
| 89,915 | Institution | 0.16% | 330,887 | |
| 54,200 | Institution | 0.10% | 199,456 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 845,148 | Institution | 1.49% | 3,110,145 | |
| 800,901 | Institution | 1.41% | 4,941,559 | |
| 399,505 | Institution | 0.71% | 2,464,946 | |
| 285,613 | Institution | 0.50% | 1,051,056 | |
| 195,016 | Institution | 0.34% | 717,659 | |
| 149,054 | Institution | 0.26% | 919,663 | |
| 141,320 | Institution | 0.25% | 527,124 | |
| 91,046 | Institution | 0.16% | 339,602 | |
| 71,994 | Institution | 0.13% | 264,938 | |
| 56,639 | Institution | 0.10% | 349,463 |
FAQ
Who Owns Design Therapeutics (DSGN)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 19.63% is held by insiders, and 67.41% is held by retail investors.
What percentage of Design Therapeutics (DSGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of Design Therapeutics (DSGN) stock is held by institutional investors.
What percentage of Design Therapeutics (DSGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.41% of Design Therapeutics (DSGN) stock is held by retail investors.
Who owns the most shares of Design Therapeutics (DSGN)?
Simeon George owns the most shares of Design Therapeutics (DSGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.